SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe

Supports capital-efficient expansion of the SLS009 clinical program into frontline AML, enabling broader U.S. and European patient enrollment ...

Blood Cancer United Expands its Beat AML® Master Clinical Trial Advancing Next-Generation Treatment

Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today that the first patient has received treatment ...

AVEO Oncology, an LG Chem company, Announces First Patient Dosed in Front-Line AML Combination Study of Ficlatuzumab

AVEO Oncology, an LG Chem company, (AVEO) announced today that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combination with azacitidine and ...
Devdiscourse

Regulatory gaps emerge as EU banks deploy AI under conflicting AML and AI rules

Under the revised EU AML/CFT package, institutions are expected to adopt more sophisticated, proactive approaches to ...

What’s Next for BSA/AML Compliance Under Trump 2.0

The Trump Administration has prioritized deregulation, aiming to reduce compliance costs under the Bank Secrecy Act (BSA).
Taiwan News

Anti-Money Laundering (AML) System Market Outlook 2030 Market to Reach US$ 7.5 Billion at 14.1% CAGR

The global anti-money laundering (AML) system market size was US$ 2.5 billion in 2021. The global anti-money laundering (AML) system market is forecast to grow to US$ 7.5 billion by 2030 by growing at ...
The Accountant on MSN

ACCA raises concerns over FCA move for AML supervision

It said that higher costs and added administrative burden could lead some companies to discontinue membership of professional ...